Kenya

© Quentin Top

Kenya

130,000

people who use drugs including 8,000 to 30,000 injecting drug users

36%

of injecting drug users are infected with HIV in Nairobi

42%

of injecting drug users are infected with HCV in Nairobi

Background

Kenya is one of the countries with the most injecting drug users. Users are stigmatised by the population and by health professionals, they are marginalised, and often have no access to the care that they need. Without the necessary treatment, with no sterile equipment available and often unaware of the risks associated with their practices because of a lack of available information, this population is one of the most vulnerable to possible infection with HIV and and hepatitis C.

 

Drug users are stigmatised by the population and by health professionals.

 

The publication of strategic documents of the issue is an encouraging sign. However, the implementation of these specific directives by the Kenyan government appears limited, in the absence of resources and trained personnel but also because of repressive policies

Drug users are stigmatised by the population and by health professionals.© Quentin Top
Drug users are stigmatised by the population and by health professionals.© Quentin Top

Activities

People at risk

combatting aids and hepatitis 

Alongside these actions on the ground, Doctors of the World works with institutions for the development of national policies on long term harm reduction. The association also supports the government in setting up targeted communication on this subject. Training and awareness building workshops are organised, focussing on substitution treatments.   

Since 2016, Doctors of the World and Doctors without Borders Belgium have been developing a pilot project on treatment for hepatitis C which feeds into the association’s advocacy for better access to treatment.

 

Nairobi
Nairobi

In 2016

We helped:

  • On average 692 users per month who visit the reception centre  

  • 484 people had a screening test for hepatitis C and 453 had a screening test for hepatitis B

  • 12 people who were co-infected with HIV and HCV were treated for HCV

Alongside these actions on the ground, Doctors of the World works with institutions for the development of national policies on long term harm reduction. The association also supports the government in setting up targeted communication on this subject. Training and awareness building workshops are organised, focussing on substitution treatments.   

Since 2016, Doctors of the World and Doctors without Borders Belgium have been developing a pilot project on treatment for hepatitis C which feeds into the association’s advocacy for better access to treatment.

 

Nairobi
Nairobi

In 2016

We helped:

  • On average 692 users per month who visit the reception centre  

  • 484 people had a screening test for hepatitis C and 453 had a screening test for hepatitis B

  • 12 people who were co-infected with HIV and HCV were treated for HCV

our institutional support

650 000 € (2018-2019)
La Mairie de Paris soutient Médecins du Monde
Doctors of the World works for the development of long term harm reduction. ©Quenti Top
Doctors of the World works for the development of long term harm reduction. ©Quenti Top

Your support

Donate

I make a donation.

Join us

I apply online.

Newsletter

I subscribe to the newsletter.

 
Global loader